Is anyone aware of recent research analyzing the role of pharmacy benefit
managers (PBMs) impact on the growth of pharmaceutical prices in the US?
There seems to be research on the effect of generics and me-too drugs on
the launch prices of new drugs and the effect of managed care (HMO's) on
physician prescribing behavior but none on PBMs specifically.
Thanks, Bryce Sutton
|